P. Gontero

Evaluation of P53 Protein Overexpression, Ki67 Proliferative Activity and Mitotic Index as Markers of Tumour Recurrence in Superficial Transitional Cell Carcinoma of the Bladder

P. Gontero, G. Casetta, A. Zitella, 2000, European Urology.

Update on epidemiology and risk factors of prostate cancer

P. Gontero, A. Zitella, A. Tizzani, 2008 .

Circadian antidiuretic hormone variation in elderly men complaining of persistent nocturia after urinary flow obstruction removal.

P. Gontero, G. Casetta, A. Tizzani, 1998, Scandinavian journal of urology and nephrology.

Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results

P. Gontero, G. Casetta, D. Pacchioni, 1999, Prostate Cancer and Prostatic Diseases.

Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer.

A. Formiconi, P. Gontero, G. Casetta, 2001, Clinica chimica acta; international journal of clinical chemistry.

[Appearance in 2 brothers of double primary neoplasms: right renal carcinoma and gastric adenocarcinoma].

P. Gontero, G. Casetta, P. Piana, 1995, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.

P. Gontero, G. Casetta, D. Pacchioni, 1997, European urology.

BTA Quantitative Assay and NMP22 Testing Compared with Urine Cytology in the Detection of Transitional Cell Carcinoma of the Bladder

A. Formiconi, P. Gontero, G. Casetta, 2000, Urologia Internationalis.

steonecrosis in Systemic Lupus Erythematosus

P. Gontero, S. Roverano, M. Bedoya, 2017 .